Format

Send to

Choose Destination
See comment in PubMed Commons below
Can J Infect Dis Med Microbiol. 2007 Jan;18 Suppl A:10A-1A.

Triple active antiretroviral regimen including enfuvirtide via the Biojector is effective and safe.

[Article in English, French; Abstract available in French from the publisher]

Author information

1
Division of Infectious Diseases, University of Toronto and Maple Leaf Medical Clinic, Toronto, Ontario.

Abstract

in English, French

For full HIV virological suppression, three fully active antiretroviral agents are required. New drug classes should be included to ensure that agents are fully active. The addition of enfuvirtide and efavirenz to the present patient's new antiretroviral regimen ensured that two fully active agents were in use in the setting of a moderate degree of nucleoside resistance and a high level of protease resistance, and where non-nucleoside reverse transcriptase inhibitors were still fully active. Both viral load and CD4 count responded favourably to this regimen. The patient received support from physicians and clinic staff in the introduction and use of enfuvirtide. To reduce injection site reactions, a needle-free injection system (Biojector) proved effective.

KEYWORDS:

Antiretroviral agents; HIV fusion inhibitors; HIV infection

PMID:
23365590
PMCID:
PMC3555493
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center